Welcome to our dedicated page for Xebra Brands news (Ticker: XBRAF), a resource for investors and traders seeking the latest updates and insights on Xebra Brands stock.
Xebra Brands Ltd. (XBRAF) maintains its position as Mexico's pioneering fully licensed cannabis company, specializing in COFEPRIS-approved CBD products and regulated cultivation operations. This news hub provides investors with essential updates on regulatory milestones, product developments, and strategic initiatives shaping the company's trajectory in the evolving cannabis sector.
Access real-time updates on XBRAF's compliance achievements, manufacturing partnerships, and market expansion efforts. Our curated news collection covers critical developments including new product authorizations, supply chain enhancements, and regulatory strategy adjustments specific to Mexico's cannabis framework.
Key coverage areas include COFEPRIS approval updates, wellness product launches, cultivation license expansions, and strategic collaborations with industry partners. Each update is verified for regulatory accuracy and operational relevance to maintain investor confidence in this complex market environment.
Bookmark this page for streamlined access to Xebra Brands' official communications and third-party analyses. Monitor the company's progress in navigating Mexico's cannabis regulations while maintaining its first-mover advantage in authorized CBD product distribution.
Xebra Brands Ltd. (CSE: XBRA, OTCQB: XBRAF) has received a court extension from the Mexican Health Regulatory Agency (COFEPRIS) to grant cannabis authorizations, now expected by the week of February 6. These authorizations will focus on cannabis with low levels of THC, primarily for hemp products and CBD sales. The company also announces significant management changes, including the resignation of founder Robert Giustra as Chairman to pursue mining ventures, along with CFO Andrew Yau and Corporate Secretary Daniela Freitas. Rodrigo Gallardo is appointed as the interim CFO and Corporate Secretary.
Xebra Brands Ltd. (CSE: XBRA, OTCQB: XBRAF) announces a favorable ruling from a District Court regarding cannabis authorizations in Mexico. The court dismissed a resolution by COFEPRIS, the Mexican health regulatory agency, as insufficient. It ordered COFEPRIS to issue full authorizations within three business days, although delays are anticipated due to holiday closures. The authorizations will apply to low-THC cannabis, focusing on hemp cultivation and CBD products, with potential opportunities in hemp plastics.
Xebra Brands Ltd. (CSE: XBRA, OTCQB: XBRAF) has announced progress regarding cannabis authorizations in Mexico. The Mexican Health Regulatory Agency, COFEPRIS, has notified Xebra Mexico that it has complied with a Supreme Court mandate for cannabis authorizations. However, Xebra asserts that COFEPRIS has not fully met this mandate and has sought federal judicial intervention. The authorizations will mainly pertain to low-THC cannabis (under 1%) for hemp cultivation and CBD products. Delays in the authorization process are anticipated due to the lack of legal precedent in Mexico.
FAQ
What is the current stock price of Xebra Brands (XBRAF)?
What is the market cap of Xebra Brands (XBRAF)?
